Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples